Tags : FitBit

PharmaShots Weekly Snapshot (Sept 14 -18, 2020)

1. AstraZeneca Reports Updated Results of Imfinzi in P-III Studies for NSCLC and ES-SCLC Published: Sept 18, 2020 | Tags:  AstraZeneca, Reports, Updated Results, Imfinzi, P-III, Studies, NSCLC, ES-SCLC 2. Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia Published: Sept 18, 2020 | Tags:  Roche, Actemra, EMPACTA study, […]Read More

Fitbit to Launch ECG App in the US and EU

Shots: Fitbit’s ECG app has received the US FDA’s 510 (k) clearance and EC’s CE marking to assess heart rhythm for atrial fibrillation (AFib). The ECG app will be available in Oct’2020 to the users on the Fitbit Sense smartwatch The company has launched a multi-site clinical trial across the US, to detect AFib from […]Read More

Fitbit Reports Results of its COVID-19 Study for Early Detection

Shots: In May’2020, Fitbit has launched its COVID-19 study to build an algorithm that detects COVID-19 before symptoms starts. The study has enrolled 1000+ positive patients across the US and Canada is now delivering its first, preliminary results 90 days later The study demonstrated that its devices could detect ~50% of COVID-19 cases one day […]Read More

PharmaShots Weekly Snapshot (May 04-08, 2020)

1.Fitbit Launches Heart Study to Validate its Wearable Technology for Identifying Atrial Fibrillation Published: May 06, 2020 | Tags: Fitbit, Launches, Heart Study, Validate, Wearable Technology, Identifying, Atrial Fibrillation 2.  Celltrion Launches Remsima SC (biosimilar, infliximab) for the Treatment of Autoimmune Diseases in the Netherlands Published: May 07, 2020 | Tags: Celltrion, Launches, Remsima SC, biosimilar, […]Read More

Fitbit Launches Heart Study to Validate its Wearable Technology for

Shots: Fitbit launched the Fitbit Heart Study, which focuses to validate the use of its wearables to detect AFib. The virtual study is open to Fitbit users aged 22yrs. + with a current Fitbit device and will enroll hundreds of thousands of people with its results supporting the Company’s regulatory submissions globally Fitbit’s devices use […]Read More

Google to Acquire Fitbit for ~$2.1B

Shots: Google to acquire Fitbit in all-cash transaction for $7.35/share, making the total deal value $2.1B. The transaction is expected to be closed in 2020 The acquisition will provide Google an opportunity to invests more in Wear OS as well as to introduce its wearable devices into the market. By joining Google’s resources and global […]Read More

PharmaShots Weekly Snapshot (October 14-18, 2019)

1. Johnson & Johnson Initiates Voluntarily Recall of a Single Lot of its Baby Powder in the US Published: Oct 18, 2019 | Tags: JnJ, Initiates, Voluntarily, Recall, Baby Powder, US 2. AbbVie’s Rinvoq (Upadacitinib) Receives CHMP Positive Opinion to Treat Moderate to Severe Active Rheumatoid Arthritis Published: Oct 18, 2019 | Tags: AbbVie, Rinvoq, Upadacitinib, Receives, […]Read More

Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation

Shots: The BMS-Pfizer Alliance and Fitbit collaborate to develop educational content and guidance, supporting patients with a high risk of AFib. The companies will focus on providing information to encourage patients to have a discussion with their physicians, following the FDA clearance of AFib detection software on Fitbit devices The collaboration helps to bridge the […]Read More

FitBit and National Institutes of Health (NIH) Launches a Digital

Shots: The BYOD project is initiated for All of Us Research Program, enrolling 1M participants to gather collective data for improving the ability of preventing and treating diseases based on lifestyle, environment and genetics The FitBit device helps in collecting real-world, real-time data using their own account with the program and manually adding the information […]Read More